Notice NOT-AA-22-015 from the NIH Guide for Grants and Contracts

Notice NOT-HD-22-038 from the NIH Guide for Grants and Contracts

Notice NOT-CA-22-127 from the NIH Guide for Grants and Contracts

Funding Opportunity RFA-HG-22-020 from the NIH Guide for Grants and Contracts. The purpose of this FOA is to solicit applications for development, maintenance, and user support for the NHGRI Genomic Data Science Analysis, Visualization, and Informatics Lab-space (AnVIL). AnVIL is a scalable and interoperable resource for the basic and clinical genomic research communities that leverages a cloud-based infrastructure to democratize data access, sharing, and computing across large genomic and genomic-related datasets. This is a limited competition RFA. Only recipient organizations funded under RFA-HG-17-011 are eligible to apply.

Notice NOT-NS-23-025 from the NIH Guide for Grants and Contracts

Funding Opportunity PAR-22-225 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites submission of investigator-initiated Program Project (P01) applications. The proposed programs should address scientific areas relevant to the NIAID mission including: biology and pathogenesis of infectious microbes, including HIV; host-microbe interactions; mechanisms regulating immune system development and function across the lifespan, and in response to infectious pathogens; immune dysfunction resulting in allergy, asthma, autoimmunity, immunodeficiency, or transplant rejection; and translational research to develop vaccines, therapeutics, and diagnostics to prevent and treat infectious and immune-mediated diseases. Each P01 application submitted to this FOA must include at least two related, synergistic research projects that share a common central theme, focus, and/or overall objective; and an administrative core. A P01 may include scientific cores, if needed for the proposed research.

Funding Opportunity RFA-CA-22-055 from the NIH Guide for Grants and Contracts. The overall goal of this FOA is to establish an agile and effective network infrastructure that undertakes collaborative research to discover molecularly or immunologically targeted agents designed to prevent or intercept oncogenic process in high-risk populations for precision cancer prevention and interception.

Notice NOT-AG-22-030 from the NIH Guide for Grants and Contracts

Notice NOT-HL-22-043 from the NIH Guide for Grants and Contracts

Notice NOT-HG-22-034 from the NIH Guide for Grants and Contracts

Notice NOT-RM-23-003 from the NIH Guide for Grants and Contracts

Notice NOT-OD-22-212 from the NIH Guide for Grants and Contracts

Notice NOT-OD-22-207 from the NIH Guide for Grants and Contracts

Funding Opportunity PAR-22-129 from the NIH Guide for Grants and Contracts. The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) announces a program that provides NIDDK-supported K01, K08, K23, and K25 recipients the opportunity to apply for Small Grant (R03) support at some point during the latter years of their award period of their K award. Through the use of this mechanism, the NIDDK is seeking to enhance the capability of its K01, K08, K23, and K25 award recipients to conduct research as they complete their transition to fully independent investigator status. The R03 grant mechanism supports different types of projects, including pilot and feasibility studies; secondary analysis of existing data; small, self-contained research projects; development of research methodology; and development of new research technology. The R03 is, therefore, intended to support research projects that can be carried out in a short period of time with limited resources and that may provide preliminary data to support a subsequent R01, or equivalent, application.

Notice NOT-NS-22-115 from the NIH Guide for Grants and Contracts

Notice NOT-TW-22-006 from the NIH Guide for Grants and Contracts

Notice NOT-NS-23-023 from the NIH Guide for Grants and Contracts

Funding Opportunity PA-22-251 from the NIH Guide for Grants and Contracts. The purpose of this individual postdoctoral research training fellowship is to enhance the research training of promising postdoctoral candidates who have the potential to become productive, independent investigators in health services research, with a research interest in areas and priorities relevant to the mission of AHRQ. This Notice of Funding Opportunity (NOFO) does not allow applicants to propose to lead an independent clinical trial but does allow applicants to propose research experience in a clinical trial led by a sponsor or co-sponsor.

Funding Opportunity RFA-HD-23-023 from the NIH Guide for Grants and Contracts. This funding opportunity announcement (FOA) encourages applications for institutional research career development (K12) programs that support mentored research and career development experiences for scholars pursuing clinical, translational, and/or basic research in pediatric therapeutics. This program constitutes a national network of mentors and scholars, in contrast to K12 programs that are based solely at a single applicant institution.The primary purpose of this FOA is to ensure that a pipeline of diverse and highly trained workforce is available in pediatric pharmacology-related clinical and biomedical fields that currently have a limited number of researchers. This FOA will support essential research career development opportunities and ensure protected time to pursue impactful research experiences for new faculty-level clinical pharmacologists, fostering the transition to productive highly skilled clinical pharmacologist investigators. This initiative proposes to expand and strengthen the community of clinical pharmacologist investigators engaged in pediatric clinical pharmacology research.

Funding Opportunity RFA-OD-22-013 from the NIH Guide for Grants and Contracts. The Office of Research Infrastructure Programs (ORIP) encourages grant applications aimed at developing, characterizing or improving animal models of human diseases; improving access to information about or generated from the use of animal models of human disease; or improving diagnosis and control of diseases of laboratory animals. The animal models, related materials, or technological tools developed must be broadly applicable to the scientific interests of two or more NIH Institutes or Centers (ICs) and must evaluate diseases and processes that impact multiple body systems in order to align with the ORIPs NIH-wide mission and programs. Applications must describe the need for and the potential impact of the proposed resources on the research community across a range of scientific disciplines supported by multiple NIH ICs. Applications to develop models that relate strictly to a specific disease or a select area of research or that do not have a broad impact on the NIH-wide research community will not be considered acceptable. Projects that predominantly address the research interests of one NIH IC but are only peripherally related to the research interests of other ICs will also not be acceptable for this funding opportunity announcement (FOA).